Mixtard 50 HM 100IU/ml Penfill (3ml Each)
Marketer
Novo Nordisk India Pvt Ltd
Salt Composition
Insulin Isophane (50%) + Human insulin (50%)
Overview Mixtard 50 HM 100IU/ml Penfill (3ml Each)
Insulin Aspart/Isophane 50/50 (100 IU/ml) Penfill cartridges (3ml each) combine intermediate and rapid-acting insulin types for managing both type 1 and type 2 diabetes in adults and children. This dual-action insulin improves glycemic control by regulating blood sugar levels. It's typically prescribed alongside other diabetes medications, administered subcutaneously as instructed by your healthcare provider, ideally 15 minutes prior to or within 20 minutes post-meal. Discontinuation requires your doctor's approval. Successful treatment involves this medication, coupled with a healthy diet, regular physical activity, and weight management as advised. Regular blood glucose monitoring is crucial for dose adjustment. Hypoglycemia (low blood sugar) is a common side effect; accurate dosing, consistent meals, and regular blood sugar checks are vital for prevention, as is avoiding excessive alcohol. Injection site reactions (redness, swelling) may occur, alongside weight gain, rash, edema, or itching. Avoid use during hypoglycemic episodes. Individuals with kidney, liver, or heart conditions, or those pregnant or breastfeeding, must consult their doctor before starting or modifying treatment.
Uses of Mixtard 50 HM 100IU/ml Penfill (3ml Each)
Managing Diabetic Conditions
Major Benefits of Mixtard 50 HM 100IU/ml Penfill (3ml Each):
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Mixtard 50 HM 100IU/ml Penfill (3ml Each):
- Hypoglycemia (low blood glucose level)
- Injection site reactions (pain, swelling, redness)
- Weight gain
How to use Mixtard 50 HM 100IU/ml Penfill (3ml Each):
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mixtard 50 HM 100IU/ml Penfill (3ml Each) works:
Isophane insulin offers extended action, contrasting with the rapid onset of human insulin. Their combined use achieves consistent, prompt blood glucose management through enhanced glucose uptake in muscle and adipose tissue, and reduced hepatic glucose production.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mixtard 50 HM 100IU/ml Penfill (3ml Each) with alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
Insulin human (Mixtard 50 HM 100 IU/mL Penfill, 3 mL cartridges) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Insulin human (Mixtard 50 HM 100 IU/ml) Penfill cartridges (3ml each) pose no known breastfeeding safety risk. Research in humans indicates minimal drug transfer to breast milk, presenting negligible infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Mixtard 50 HM 100 IU/ml Penfill (3 ml each) cautiously. Dosage modification might be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dose adjustments.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Mixtard 50 HM 100 IU/ml Penfill (3 ml each). Dosage modification of Mixtard 50 HM 100 IU/ml Penfill (3 ml each) may be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide appropriate dosage changes.
What if you forget to take Mixtard 50 HM 100IU/ml Penfill (3ml Each) :
Should you inadvertently omit a dose of Mixtard 50 HM 100 IU/ml Penfill (3ml units), elevated blood glucose (hyperglycemia) could result. Monitor your blood sugar and adjust subsequent dosing as needed.
Facts to Know About Mixtard 50 HM 100IU/ml Penfill (3ml Each)
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently